Trials / Completed
CompletedNCT00944723
Impact of Mass Zinc Fortification Programs on Plasma Zinc Concentration
Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of mass zinc fortification programs.
Detailed description
The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to adult men (fortified at a level consistent with currently proposed levels). The following specific steps will be completed: 1. Zinc-fortified breads prepared from zinc-fortified wheat flour will be developed with assistance from experts in food technology. 2. A four-week feeding trial will be implemented to assess the change in plasma zinc concentration among young adult men who receive: a) bread fortified with a moderate amount of zinc and a liquid vitamin preparation between meals; b) bread fortified with a large amount zinc and a liquid vitamin preparation between meals; c) non-zinc-fortified bread and a liquid vitamin preparation between meals \[negative control group\]; and d) non-zinc-fortified bread and a zinc-containing liquid vitamin preparation between meals \[positive control group\].
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Zinc-fortified bread | Bread made with zinc-fortified wheat flour |
| DIETARY_SUPPLEMENT | Zinc supplement | Liquid supplement with zinc |
| DIETARY_SUPPLEMENT | Non-fortified bread | Daily consumption of non-fortified bread |
| DIETARY_SUPPLEMENT | Placebo supplement | Daily intake of placebo supplement |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-01-01
- Completion
- 2010-02-01
- First posted
- 2009-07-23
- Last updated
- 2010-02-19
Locations
1 site across 1 country: Senegal
Source: ClinicalTrials.gov record NCT00944723. Inclusion in this directory is not an endorsement.